AKT1 and dysplasia: Recent studies have also further highlighted the potential central role of Akt in Barrett’s oesophageal cancer progression: signalling via the insulin/insulin-like growth factor-1 axis and HER2 receptor also activates Akt along the Barrett’s dysplasia-cancer sequence [38].